ZYNEX INC (ZYXI) Stock Fundamental Analysis
USA - NASDAQ:ZYXI - US98986M1036 - Common Stock
1.15 USD
-0.1 (-8%)
1.1493 USD
0 (-0.06%)
We assign a fundamental rating of 2 out of 10 to ZYXI. ZYXI was compared to 189 industry peers in the Health Care Equipment & Supplies industry. ZYXI may be in some trouble as it scores bad on both profitability and health. ZYXI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ZYXI had negative earnings in the past year.
ZYXI had a negative operating cash flow in the past year.
ZYXI had positive earnings in each of the past 5 years.
In the past 5 years ZYXI always reported a positive cash flow from operatings.
1.2 Ratios
ZYXI has a Return On Assets (-33.35%) which is in line with its industry peers.
ZYXI has a worse Return On Equity (-2272.96%) than 89.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.35% | ||
| ROE | -2272.96% | ||
| ROIC | N/A |
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of ZYXI has declined.
ZYXI's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 75.62%, ZYXI belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
ZYXI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ZYXI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.62% |
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
ZYXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZYXI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ZYXI has less shares outstanding
The debt/assets ratio for ZYXI is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.77, we must say that ZYXI is in the distress zone and has some risk of bankruptcy.
ZYXI has a Altman-Z score of 0.77. This is comparable to the rest of the industry: ZYXI outperforms 47.09% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that ZYXI is somewhat dependend on debt financing.
The Debt to Equity ratio of ZYXI (0.56) is worse than 62.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.77 |
ROIC/WACCN/A
WACC6.46%
2.3 Liquidity
ZYXI has a Current Ratio of 0.62. This is a bad value and indicates that ZYXI is not financially healthy enough and could expect problems in meeting its short term obligations.
ZYXI has a worse Current ratio (0.62) than 91.53% of its industry peers.
A Quick Ratio of 0.45 indicates that ZYXI may have some problems paying its short term obligations.
The Quick ratio of ZYXI (0.45) is worse than 92.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.45 |
3. Growth
3.1 Past
ZYXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -368.57%.
ZYXI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.77% yearly.
Looking at the last year, ZYXI shows a very negative growth in Revenue. The Revenue has decreased by -25.21% in the last year.
The Revenue has been growing by 33.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-368.57%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-1750%
Revenue 1Y (TTM)-25.21%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-55.32%
3.2 Future
ZYXI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.28% yearly.
Based on estimates for the next years, ZYXI will show a decrease in Revenue. The Revenue will decrease by -7.81% on average per year.
EPS Next Y-1592.23%
EPS Next 2Y-165.75%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue Next Year-52.62%
Revenue Next 2Y-28.78%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ZYXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZYXI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as ZYXI's earnings are expected to decrease with -60.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-165.75%
EPS Next 3Y-60.01%
5. Dividend
5.1 Amount
No dividends for ZYXI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.15
-0.1 (-8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.33%
Inst Owner Change-0.5%
Ins Owners48.26%
Ins Owner Change0.15%
Market Cap34.84M
Revenue(TTM)144.81M
Net Income(TTM)-28662000
Analysts80
Price Target4.66 (305.22%)
Short Float %21.96%
Short Ratio36.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-65.69%
DP-0.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.91%
Min EPS beat(2)-229.01%
Max EPS beat(2)-34.8%
EPS beat(4)1
Avg EPS beat(4)-91.12%
Min EPS beat(4)-229.01%
Max EPS beat(4)21.1%
EPS beat(8)3
Avg EPS beat(8)-60.9%
EPS beat(12)7
Avg EPS beat(12)-15.64%
EPS beat(16)10
Avg EPS beat(16)-10.53%
Revenue beat(2)0
Avg Revenue beat(2)-17.83%
Min Revenue beat(2)-20.18%
Max Revenue beat(2)-15.48%
Revenue beat(4)0
Avg Revenue beat(4)-13.82%
Min Revenue beat(4)-20.18%
Max Revenue beat(4)-3.62%
Revenue beat(8)0
Avg Revenue beat(8)-10.33%
Revenue beat(12)1
Avg Revenue beat(12)-7.09%
Revenue beat(16)1
Avg Revenue beat(16)-5.97%
PT rev (1m)0%
PT rev (3m)-23.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-68.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 27.63 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS4.78
BVpS0.04
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -33.35% | ||
| ROE | -2272.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.62% | ||
| FCFM | N/A |
ROA(3y)8.05%
ROA(5y)9.92%
ROE(3y)18.36%
ROE(5y)18.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.93%
ROCE(5y)15.14%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.42%
OM growth 5Y-33.75%
PM growth 3Y-50.87%
PM growth 5Y-40.5%
GM growth 3Y0.14%
GM growth 5Y-0.29%
F-Score4
Asset Turnover1.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 10.42% | ||
| Cap/Sales | 0.33% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.45 | ||
| Altman-Z | 0.77 |
F-Score4
WACC6.46%
ROIC/WACCN/A
Cap/Depr(3y)18.03%
Cap/Depr(5y)28.76%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.58%
Profit Quality(3y)218.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-368.57%
EPS 3Y-41.04%
EPS 5Y-18.77%
EPS Q2Q%-1750%
EPS Next Y-1592.23%
EPS Next 2Y-165.75%
EPS Next 3Y-60.01%
EPS Next 5Y-28.28%
Revenue 1Y (TTM)-25.21%
Revenue growth 3Y13.86%
Revenue growth 5Y33.42%
Sales Q2Q%-55.32%
Revenue Next Year-52.62%
Revenue Next 2Y-28.78%
Revenue Next 3Y-15.7%
Revenue Next 5Y-7.81%
EBIT growth 1Y-291.11%
EBIT growth 3Y-35.57%
EBIT growth 5Y-11.61%
EBIT Next Year-252.95%
EBIT Next 3Y-38.41%
EBIT Next 5Y-9.53%
FCF growth 1Y-153.82%
FCF growth 3Y24.19%
FCF growth 5Y14.61%
OCF growth 1Y-148.38%
OCF growth 3Y22.32%
OCF growth 5Y15.09%
ZYNEX INC / ZYXI FAQ
What is the ChartMill fundamental rating of ZYNEX INC (ZYXI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ZYXI.
What is the valuation status of ZYNEX INC (ZYXI) stock?
ChartMill assigns a valuation rating of 0 / 10 to ZYNEX INC (ZYXI). This can be considered as Overvalued.
What is the profitability of ZYXI stock?
ZYNEX INC (ZYXI) has a profitability rating of 3 / 10.
Can you provide the financial health for ZYXI stock?
The financial health rating of ZYNEX INC (ZYXI) is 1 / 10.
What is the earnings growth outlook for ZYNEX INC?
The Earnings per Share (EPS) of ZYNEX INC (ZYXI) is expected to decline by -1592.23% in the next year.